[go: up one dir, main page]

ES516521A0 - "metodo de preparar intermedios de ftalimidinas, ftalacinonas y similares". - Google Patents

"metodo de preparar intermedios de ftalimidinas, ftalacinonas y similares".

Info

Publication number
ES516521A0
ES516521A0 ES516521A ES516521A ES516521A0 ES 516521 A0 ES516521 A0 ES 516521A0 ES 516521 A ES516521 A ES 516521A ES 516521 A ES516521 A ES 516521A ES 516521 A0 ES516521 A0 ES 516521A0
Authority
ES
Spain
Prior art keywords
phthalacinones
phthalimidines
preparing intermediates
intermediates
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES516521A
Other languages
English (en)
Other versions
ES8400402A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pharmaceutical Corp
Original Assignee
USV Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pharmaceutical Corp filed Critical USV Pharmaceutical Corp
Publication of ES8400402A1 publication Critical patent/ES8400402A1/es
Publication of ES516521A0 publication Critical patent/ES516521A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/021,2-Oxazines; Hydrogenated 1,2-oxazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
ES516521A 1980-10-31 1982-10-15 "metodo de preparar intermedios de ftalimidinas, ftalacinonas y similares". Granted ES516521A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/202,812 US4331600A (en) 1980-10-31 1980-10-31 Intermediates for the synthesis of phthalimidines

Publications (2)

Publication Number Publication Date
ES8400402A1 ES8400402A1 (es) 1983-11-16
ES516521A0 true ES516521A0 (es) 1983-11-16

Family

ID=22751373

Family Applications (2)

Application Number Title Priority Date Filing Date
ES506683A Expired ES8301917A1 (es) 1980-10-31 1981-10-29 Procedimiento para preparar intermedios de ftalimidinas y ftalacinonas
ES516521A Granted ES516521A0 (es) 1980-10-31 1982-10-15 "metodo de preparar intermedios de ftalimidinas, ftalacinonas y similares".

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES506683A Expired ES8301917A1 (es) 1980-10-31 1981-10-29 Procedimiento para preparar intermedios de ftalimidinas y ftalacinonas

Country Status (10)

Country Link
US (1) US4331600A (es)
EP (1) EP0051215B1 (es)
JP (1) JPS57106661A (es)
AR (1) AR231128A1 (es)
AU (1) AU554712B2 (es)
CA (1) CA1172634A (es)
DE (1) DE3176009D1 (es)
DK (1) DK479981A (es)
ES (2) ES8301917A1 (es)
ZA (1) ZA817433B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005065046A2 (en) * 2004-01-02 2005-07-21 Ipca Laboratories Limited An efficient industrial process for 3-hydroxy-3-(3’-sulfamyl-4’-chlorophenyl)phtalimidine
GB0419481D0 (en) * 2004-09-02 2004-10-06 Cancer Rec Tech Ltd Isoindolin-1-one derivatives
JP4936512B2 (ja) * 2006-02-24 2012-05-23 公立大学法人大阪府立大学 光解裂性環状化合物
JP5335675B2 (ja) 2006-07-25 2013-11-06 セファロン、インク. ピリジジノン誘導体
GB0811643D0 (en) 2008-06-25 2008-07-30 Cancer Rec Tech Ltd New therapeutic agents
GB201517217D0 (en) 2015-09-29 2015-11-11 Astex Therapeutics Ltd And Cancer Res Technology Ltd Pharmaceutical compounds
GB201517216D0 (en) 2015-09-29 2015-11-11 Cancer Res Technology Ltd And Astex Therapeutics Ltd Pharmaceutical compounds
WO2018158777A1 (en) 2017-03-01 2018-09-07 Mylan Laboratories Limited Improved process for the preparation of chlorthalidone
GB201704965D0 (en) 2017-03-28 2017-05-10 Astex Therapeutics Ltd Pharmaceutical compounds
GB201704966D0 (en) 2017-03-28 2017-05-10 Astex Therapeutics Ltd Pharmaceutical compounds
CN109942473B (zh) * 2019-05-16 2020-09-15 贵州大学 一种无催化剂合成内酰胺衍生物的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3055904A (en) * 1957-11-04 1962-09-25 Geigy Chem Corp New isoindoline derivatives
GB1025904A (en) * 1963-03-20 1966-04-14 Ici Ltd Pharmaceutical compositions containing phthalimidine derivatives
US3296276A (en) * 1964-07-15 1967-01-03 Schering Corp Novel 1-oxo-3-phenyl isoindolines
US3699119A (en) * 1968-06-19 1972-10-17 Sandoz Ag Process for 5 h-imidazo(2,1-a)isoindoles
US4188330A (en) * 1978-10-10 1980-02-12 The Dow Chemical Company Substituted phthalide derivatives

Also Published As

Publication number Publication date
AU554712B2 (en) 1986-08-28
ES8400402A1 (es) 1983-11-16
US4331600A (en) 1982-05-25
DK479981A (da) 1982-05-01
CA1172634A (en) 1984-08-14
JPS57106661A (en) 1982-07-02
ES506683A0 (es) 1983-01-16
EP0051215B1 (en) 1987-03-18
EP0051215A3 (en) 1982-07-28
DE3176009D1 (en) 1987-04-23
AU7694081A (en) 1982-05-06
EP0051215A2 (en) 1982-05-12
ZA817433B (en) 1982-09-29
AR231128A1 (es) 1984-09-28
ES8301917A1 (es) 1983-01-16

Similar Documents

Publication Publication Date Title
FI852516L (fi) Anordning foer dosering av tillvaext befraemjande aemnen.
ES516523A0 (es) "metodo de preparar compuestos benzoheterociclicos".
IT8122682A0 (it) Loro preparazione. interferoni e procedimento per la
FI813058L (fi) Foerbaettringar beroerande 2,4-disubstituerade tiazolderivat
FI862231A0 (fi) Anordning foer utkastning av spelbollar.
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
IT8124141A0 (it) Procedimento per lapreparazione di 4'-deossi-daunorubicina 4'-deossi-doxorubicina.
ES516521A0 (es) "metodo de preparar intermedios de ftalimidinas, ftalacinonas y similares".
IT8122083A0 (it) Chinossalin-2-il-etenil-chetoni eprocedimento per la loro preparazione.
NO158948C (no) Fremgangsmaate for fremstilling av enzymet kolesterase.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
FI813666L (fi) Foerfarande foer framstaellning av 3,4-bis-substituerade 1,2,5-oxdiazol-2-oxider
NO811628L (no) Fremgangsmaate for fremstilling av karbapenam- og karbapen-2-em-derivater.
NO157652C (no) Fremgangsmaate for fremstilling av 3-pikolin.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
NO810114L (no) Fremgangsmaate for fremstilling av kijanimicin.
NL7908512A (nl) Nieuwe azepino1,2,3-lm-beta-carboline derivaten en de bereidingswijze en toepassing daarvan.
ES514334A0 (es) "metodo de obtencion de derivados de quinoxalina-1,4-dioxido".
IT8026345A0 (it) Procedimento e perfezionamento per la preparazione di dicumilperossido.
IT8224818A0 (it) Procedimento per la preparazione del7-metil-3-metilen-7-otten-1-il-propionato.
ES511894A0 (es) "metodo de preparar derivados isoxazol-5-il-metilenoxiguanidinicos".
ES512697A0 (es) "metodo de preparar compuestos metilquinoxalin-1,4-dioxidicos".
IT8125583A0 (it) Procedimento per l'estrazione di brodi di fermentazione nonfiltrati.
ES512891A0 (es) "procedimiento para la preparacion de nuevas penicilinas".
NO159862C (no) Fremgangsmaate for fremstilling av enzymet uricase.